ConductScience.org, home

Paper10691731

Loss of PTEN facilitates HIF-1-mediated gene expression.

Zundel W and 11 others. Genes Dev, 2000. Cited by 682 papers, by iCite.

Cite this record

ConductScience Library. Loss of PTEN facilitates HIF-1-mediated gene expression. Papers, record 10691731. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10691731

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of PTEN facilitates HIF-1-mediated gene expression.
PubMed
Journal
Genes Dev
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
682
iCite
Relative citation ratio, by iCite
12.4
iCite
Revised in PubMed
2021-12-03
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zundel WW
2Schindler CC
3Haas-Kogan DD
4Koong AA
5Kaper FF
6Chen EE
7Gottschalk ARA R
8Ryan HEH E
9Johnson RSR S
10Jefferson ABA B
11Stokoe DD
12Giaccia AJA J

Source PubMed

Download CSV of authors

Topics36

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
DNA-Binding ProteinsMajor topic
Gene Expression Regulation, NeoplasticMajor topic
GlioblastomaMajor topic
Insulin-Like Growth Factor IMajor topic
Neoplasm ProteinsMajor topic
Nuclear ProteinsMajor topic
Phosphoric Monoester HydrolasesMajor topic
Protein Serine-Threonine KinasesMajor topic
Transcription FactorsMajor topic
Tumor Suppressor ProteinsMajor topic
Apoptosis
Cell Hypoxia
Culture Media, Serum-Free
Cyclooxygenase 1
Disease Progression
Endothelial Growth Factors
Gene Deletion
Genetic Complementation Test
Humans
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Isoenzymes
Lymphokines
Membrane Proteins
PTEN Phosphohydrolase
Phosphofructokinase-1
Phosphotransferases (Alcohol Group Acceptor)
Prostaglandin-Endoperoxide Synthases
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-akt
Recombinant Fusion Proteins
Transfection
Tumor Cells, Cultured
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 CA009302NCI NIH HHSUnited StatesT32CA009302PubMed and NIHNIH RePORTER
CA-73832NCI NIH HHSUnited StatesR01CA073832PubMed and NIHNIH RePORTER
P01 CA067166NCI NIH HHSUnited StatesP01CA067166PubMed and NIHNIH RePORTER
CA-67166NCI NIH HHSUnited StatesP01CA067166PubMed and NIHNIH RePORTER
CA-09302NCI NIH HHSUnited StatesT32CA009302PubMed and NIHNIH RePORTER

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110535940Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10535940PubMed
29184223Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.EMBO J1997https://conductscience.org/library/papers/9184223PubMed
37807192High dose chemotherapy for the treatment of malignant brain tumors.J Neurooncol1994https://conductscience.org/library/papers/7807192PubMed
47701328Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase.Science1995https://conductscience.org/library/papers/7701328PubMed
58538748Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.Nature1996https://conductscience.org/library/papers/8538748PubMed
68702995Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation.J Biol Chem1996https://conductscience.org/library/papers/8702995PubMed
78910616Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma.J Biol Chem1996https://conductscience.org/library/papers/8910616PubMed
89049887Angiogenesis in brain tumors; pathobiological and clinical aspects.J Neurooncol1997https://conductscience.org/library/papers/9049887PubMed
99072974PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.Science1997https://conductscience.org/library/papers/9072974PubMed
109090379Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.Nat Genet1997https://conductscience.org/library/papers/9090379PubMed
119140396Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.Nat Genet1997https://conductscience.org/library/papers/9140396PubMed
129241266Germline mutations in PTEN are present in Bannayan-Zonana syndrome.Nat Genet1997https://conductscience.org/library/papers/9241266PubMed
139271594A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.J Exp Med1997https://conductscience.org/library/papers/9271594PubMed
149346240Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.Cell1997https://conductscience.org/library/papers/9346240PubMed
159345014
Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element.
Blood1997https://conductscience.org/library/papers/9345014PubMed
169593664The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.J Biol Chem1998https://conductscience.org/library/papers/9593664PubMed
179606183HIF-1 alpha is required for solid tumor formation and embryonic vascularization.EMBO J1998https://conductscience.org/library/papers/9606183PubMed
189685326Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway.J Biol Chem1998https://conductscience.org/library/papers/9685326PubMed
199685702Mutagenesis induced by the tumor microenvironment.Mutat Res1998https://conductscience.org/library/papers/9685702PubMed
209697695Pten is essential for embryonic development and tumour suppression.Nat Genet1998https://conductscience.org/library/papers/9697695PubMed

See all 38 referencesDownload CSV of references

Cited by288

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 682 citations.

PMIDTitleJournalYearIn PapersSource
42820287HIF-1-mediated PPME1 expression promotes breast cancer progression via AKT activation and β-catenin recruitment.J Clin Invest2026https://conductscience.org/library/papers/42820287PubMed
42802108Methyl 4-O-Demethylbarbatate Destabilises HIF-1α and Enhances Temozolomide Sensitivity in Glioma Cells.Cell Prolif2026https://conductscience.org/library/papers/42802108PubMed
42258782Clonal Evolution of Endometriosis to Peritoneal Endometrioid Carcinoma via PTEN Biallelic Inactivation: A Case Report With Integrated Genomic and Pathological Profiling.JCO Precis Oncol2026https://conductscience.org/library/papers/42258782PubMed
42121269Normoxic HIFα-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity.Cancer Metab2026https://conductscience.org/library/papers/42121269PubMed
41883440Deciphering the interplay between hypoxia, angiogenesis, and endoplasmic reticulum stress in carcinogenesis: A narrative review.World J Exp Med2026https://conductscience.org/library/papers/41883440PubMed
41450919Metabolism of glioblastoma: a review of metabolic adaptations and metabolic therapeutic interventions.Front Oncol2025https://conductscience.org/library/papers/41450919PubMed
41413686EGLN1 (PHD2) role in tumor microenvironment: insights for therapeutic targeting.Exp Mol Med2025https://conductscience.org/library/papers/41413686PubMed
40387552Ephedrine Attenuates LPS-Induced Acute Lung Injury in Mice by Inhibiting OTUB1 and Promoting K48 Ubiquitination of HIF1α.J Cell Mol Med2025https://conductscience.org/library/papers/40387552PubMed
40273234Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity.Science2025https://conductscience.org/library/papers/40273234PubMed
40244148Exploring Multi-Target Therapeutic Strategies for Glioblastoma via Endogenous Network Modeling.Int J Mol Sci2025https://conductscience.org/library/papers/40244148PubMed
39875616Tumour hypoxia in driving genomic instability and tumour evolution.Nat Rev Cancer2025https://conductscience.org/library/papers/39875616PubMed
39866010DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance.Cell Prolif2025https://conductscience.org/library/papers/39866010PubMed
39825916HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.Cell Mol Life Sci2025https://conductscience.org/library/papers/39825916PubMed
39761690Adaptive Significance of Non-coding RNAs: Insights from Cancer Biology.Mol Biol Evol2025https://conductscience.org/library/papers/39761690PubMed
39698262Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/39698262PubMed
39549201Carotenoids as modulators of the PI3K/Akt/mTOR pathway: innovative strategies in cancer therapy.Med Oncol2024https://conductscience.org/library/papers/39549201PubMed
39470609Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery.Transcription2025https://conductscience.org/library/papers/39470609PubMed
39346924Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape.Front Immunol2024https://conductscience.org/library/papers/39346924PubMed
39158100Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies.Blood Adv2024https://conductscience.org/library/papers/39158100PubMed
39055895Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications.Oncol Res2024https://conductscience.org/library/papers/39055895PubMed

See all 288 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
PFKM5213PubTator's text mininghttps://conductscience.org/library/genes/5213NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene
PTGS15742PubTator's text mininghttps://conductscience.org/library/genes/5742NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10691731

GET https://conductscience.org/api/papers/v1/10691731/references?page=2